
Precedex(TM) is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. Precedex should be administered by...
Product Catalog - Baxter
Jan 1, 2025 · Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride injection, 400 mcg/100 mL (4 mcg/mL) in Galaxy Container. Liquid Premix. NDC 0338-9557-12. Please refer to full Prescribing Information
Dexmedetomidine in Sodium Chloride Injection: Package Insert ...
Dexmedetomidine hydrochloride in 0.9% sodium chloride injection is an alpha 2 -adrenergic receptor agonist indicated for: Sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting.
Dexmedetomidine in 0.9% sodium chloride (Precedex Premix) Solution for Intravenous Infusion is ready to be used. It is supplied as a clear, colorless, isotonic solution with a pH between 4.5 to 8.0. The solution is preservative-free and contains no additives or chemical stabilizers.
Dexmedetomidine Hydrochloride 4 mcg/mL Premix for …
Aug 20, 2019 · Pfizer did not provide a reason for the shortage. WG Critical Care began marketing premixed bags in November 2018. Baxter has dexmedetomidine premixed bags available. All marketed presentations are available. Updated August 20, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist.
PRECEDEX is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. PRECEDEX should be administered by continuous...
Precedex: Package Insert / Prescribing Info - Drugs.com
Feb 6, 2025 · PRECEDEX is indicated for sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting. PRECEDEX should be administered by continuous infusion not to exceed 24 hours.
PRECEDEX Dosage and Administration - Pfizer Medical Information
PRECEDEX in 0.9% Sodium Chloride Injection is supplied in glass containers containing a premixed, ready to use dexmedetomidine hydrochloride solution in 0.9% sodium chloride in water. No further dilution of these preparations is necessary.
PRECEDEX™ (dexmedetomidine hydrochloride) - Pfizer
PRECEDEX™ (dexmedetomidine hydrochloride) This product information is intended only for residents of the United States. for Consumers: PRECEDEX™ - U.S. Medical Information Page - patient information, ways to contact Pfizer Medical & other resources; for Healthcare professionals: PRECEDEX U.S. Physician Prescribing Information
PRECEDEX Description - Pfizer Medical Information
PRECEDEX (dexmedetomidine hydrochloride) in 0.9% Sodium Chloride Injection (4 mcg/mL) is a sterile, nonpyrogenic ready to use solution suitable for intravenous infusion. PRECEDEX contains dexmedetomidine hydrochloride as the active pharmaceutical ingredient.
- Some results have been removed